Generics Market Summary, Competitive Analysis and Forecast to 2027
Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
- Regional volumes are calculated as weighted averages of countries that comprise the region where volume data exists.
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2022 annual average exchange rates.
- The global generics market had total revenues of $336.9 billion in 2022, representing a compound annual growth rate (CAGR) of 7.2% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 1.8% between 2017 and 2022, to reach a total of 40.1% in 2022.
- In 2022, the growth of the global generics market decelerated, witnessing an annual growth of 7.2% due to the reduction in generic drug prices.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
- What was the size of the global generics market by value in 2022?
- What will be the size of the global generics market in 2027?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape
2 INTRODUCTION
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 GLOBAL GENERICS
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 MACROECONOMIC INDICATORS
4.1. Country data
5 GENERICS IN ASIA-PACIFIC
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 GENERICS IN EUROPE
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 MACROECONOMIC INDICATORS
7.1. Country data
8 GENERICS IN FRANCE
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 MACROECONOMIC INDICATORS
9.1. Country data
10 GENERICS IN GERMANY
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 MACROECONOMIC INDICATORS
11.1. Country data
12 GENERICS IN ITALY
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 MACROECONOMIC INDICATORS
13.1. Country data
14 GENERICS IN JAPAN
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 MACROECONOMIC INDICATORS
15.1. Country data
16 GENERICS IN AUSTRALIA
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 MACROECONOMIC INDICATORS
17.1. Country data
18 GENERICS IN CANADA
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 MACROECONOMIC INDICATORS
19.1. Country data
20 GENERICS IN CHINA
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 MACROECONOMIC INDICATORS
21.1. Country data
22 GENERICS IN THE NETHERLANDS
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 MACROECONOMIC INDICATORS
23.1. Country data
24 GENERICS IN SPAIN
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 MACROECONOMIC INDICATORS
25.1. Country data
26 GENERICS IN THE UNITED KINGDOM
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 MACROECONOMIC INDICATORS
27.1. Country data
28 GENERICS IN THE UNITED STATES
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 MACROECONOMIC INDICATORS
29.1. Country data
30 COMPANY PROFILES
30.1. Teva Pharmaceutical Industries Limited
30.2. Pfizer Inc.
30.3. Sun Pharmaceutical Industries Ltd
30.4. Viatris Inc.
30.5. Sanofi SA
30.6. Les Laboratoires Servier
30.7. STADA Arzneimittel AG
30.8. Novartis AG
30.9. Daiichi Sankyo Co Ltd
30.10. Sawai Pharmaceutical Co Ltd
30.11. Lupin Ltd
30.12. Aspen Pharmacare Holdings Ltd
30.13. Apotex, Inc.
30.14. Grand Pharmaceutical Group Limited
30.15. Esteve Group
31 APPENDIX
31.1. Methodology
31.2. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape
2 INTRODUCTION
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 GLOBAL GENERICS
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 MACROECONOMIC INDICATORS
4.1. Country data
5 GENERICS IN ASIA-PACIFIC
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 GENERICS IN EUROPE
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 MACROECONOMIC INDICATORS
7.1. Country data
8 GENERICS IN FRANCE
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 MACROECONOMIC INDICATORS
9.1. Country data
10 GENERICS IN GERMANY
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 MACROECONOMIC INDICATORS
11.1. Country data
12 GENERICS IN ITALY
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 MACROECONOMIC INDICATORS
13.1. Country data
14 GENERICS IN JAPAN
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 MACROECONOMIC INDICATORS
15.1. Country data
16 GENERICS IN AUSTRALIA
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 MACROECONOMIC INDICATORS
17.1. Country data
18 GENERICS IN CANADA
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 MACROECONOMIC INDICATORS
19.1. Country data
20 GENERICS IN CHINA
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 MACROECONOMIC INDICATORS
21.1. Country data
22 GENERICS IN THE NETHERLANDS
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 MACROECONOMIC INDICATORS
23.1. Country data
24 GENERICS IN SPAIN
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 MACROECONOMIC INDICATORS
25.1. Country data
26 GENERICS IN THE UNITED KINGDOM
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 MACROECONOMIC INDICATORS
27.1. Country data
28 GENERICS IN THE UNITED STATES
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 MACROECONOMIC INDICATORS
29.1. Country data
30 COMPANY PROFILES
30.1. Teva Pharmaceutical Industries Limited
30.2. Pfizer Inc.
30.3. Sun Pharmaceutical Industries Ltd
30.4. Viatris Inc.
30.5. Sanofi SA
30.6. Les Laboratoires Servier
30.7. STADA Arzneimittel AG
30.8. Novartis AG
30.9. Daiichi Sankyo Co Ltd
30.10. Sawai Pharmaceutical Co Ltd
30.11. Lupin Ltd
30.12. Aspen Pharmacare Holdings Ltd
30.13. Apotex, Inc.
30.14. Grand Pharmaceutical Group Limited
30.15. Esteve Group
31 APPENDIX
31.1. Methodology
31.2. About MarketLine
LIST OF TABLES
Table 1: Global generics market value: $ million, 2017-22
Table 2: Global generics market volume: %, 2017-22
Table 3: Global generics market geography segmentation: $ million, 2022
Table 4: Global generics market value forecast: $ million, 2022-27
Table 5: Global generics market volume forecast: %, 2022-27
Table 6: Global size of population (million), 2018-22
Table 7: Global gdp (constant 2005 prices, $ billion), 2018-22
Table 8: Global gdp (current prices, $ billion), 2018-22
Table 9: Global inflation, 2018-22
Table 10: Global consumer price index (absolute), 2018-22
Table 11: Global exchange rate, 2018-22
Table 12: Asia-Pacific generics market value: $ million, 2017-22
Table 13: Asia-Pacific generics market volume: %, 2017-22
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2022
Table 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Table 16: Asia-Pacific generics market volume forecast: %, 2022-27
Table 17: Europe generics market value: $ million, 2017-22
Table 18: Europe generics market volume: %, 2017-22
Table 19: Europe generics market geography segmentation: $ million, 2022
Table 20: Europe generics market value forecast: $ million, 2022-27
Table 21: Europe generics market volume forecast: %, 2022-27
Table 22: Europe size of population (million), 2018-22
Table 23: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 24: Europe gdp (current prices, $ billion), 2018-22
Table 25: Europe inflation, 2018-22
Table 26: Europe consumer price index (absolute), 2018-22
Table 27: Europe exchange rate, 2018-22
Table 28: France generics market value: $ million, 2017-22
Table 29: France generics market volume: %, 2017-22
Table 30: France generics market geography segmentation: $ million, 2022
Table 31: France generics market value forecast: $ million, 2022-27
Table 32: France generics market volume forecast: %, 2022-27
Table 33: France size of population (million), 2018-22
Table 34: France gdp (constant 2005 prices, $ billion), 2018-22
Table 35: France gdp (current prices, $ billion), 2018-22
Table 36: France inflation, 2018-22
Table 37: France consumer price index (absolute), 2018-22
Table 38: France exchange rate, 2018-22
Table 39: Germany generics market value: $ million, 2017-22
Table 40: Germany generics market volume: %, 2017-22
Table 41: Germany generics market geography segmentation: $ million, 2022
Table 42: Germany generics market value forecast: $ million, 2022-27
Table 43: Germany generics market volume forecast: %, 2022-27
Table 44: Germany size of population (million), 2018-22
Table 45: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 46: Germany gdp (current prices, $ billion), 2018-22
Table 47: Germany inflation, 2018-22
Table 48: Germany consumer price index (absolute), 2018-22
Table 49: Germany exchange rate, 2018-22
Table 50: Italy generics market value: $ million, 2017-22
Table 51: Italy generics market volume: %, 2017-22
Table 52: Italy generics market geography segmentation: $ million, 2022
Table 53: Italy generics market value forecast: $ million, 2022-27
Table 54: Italy generics market volume forecast: %, 2022-27
Table 55: Italy size of population (million), 2018-22
Table 56: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 57: Italy gdp (current prices, $ billion), 2018-22
Table 58: Italy inflation, 2018-22
Table 59: Italy consumer price index (absolute), 2018-22
Table 60: Italy exchange rate, 2018-22
Table 61: Japan generics market value: $ million, 2017-22
Table 62: Japan generics market volume: %, 2017-22
Table 63: Japan generics market geography segmentation: $ million, 2022
Table 64: Japan generics market value forecast: $ million, 2022-27
Table 65: Japan generics market volume forecast: %, 2022-27
Table 66: Japan size of population (million), 2018-22
Table 67: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 68: Japan gdp (current prices, $ billion), 2018-22
Table 69: Japan inflation, 2018-22
Table 70: Japan consumer price index (absolute), 2018-22
Table 71: Japan exchange rate, 2018-22
Table 72: Australia generics market value: $ million, 2017-22
Table 73: Australia generics market volume: %, 2017-22
Table 74: Australia generics market geography segmentation: $ million, 2022
Table 75: Australia generics market value forecast: $ million, 2022-27
Table 76: Australia generics market volume forecast: %, 2022-27
Table 77: Australia size of population (million), 2018-22
Table 78: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 79: Australia gdp (current prices, $ billion), 2018-22
Table 80: Australia inflation, 2018-22
Table 81: Australia consumer price index (absolute), 2018-22
Table 82: Australia exchange rate, 2018-22
Table 83: Canada generics market value: $ million, 2017-22
Table 84: Canada generics market volume: %, 2017-22
Table 85: Canada generics market geography segmentation: $ million, 2022
Table 86: Canada generics market value forecast: $ million, 2022-27
Table 87: Canada generics market volume forecast: %, 2022-27
Table 88: Canada size of population (million), 2018-22
Table 89: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 90: Canada gdp (current prices, $ billion), 2018-22
Table 91: Canada inflation, 2018-22
Table 92: Canada consumer price index (absolute), 2018-22
Table 93: Canada exchange rate, 2018-22
Table 94: China generics market value: $ million, 2017-22
Table 95: China generics market volume: %, 2017-22
Table 96: China generics market geography segmentation: $ million, 2022
Table 97: China generics market value forecast: $ million, 2022-27
Table 98: China generics market volume forecast: %, 2022-27
Table 1: Global generics market value: $ million, 2017-22
Table 2: Global generics market volume: %, 2017-22
Table 3: Global generics market geography segmentation: $ million, 2022
Table 4: Global generics market value forecast: $ million, 2022-27
Table 5: Global generics market volume forecast: %, 2022-27
Table 6: Global size of population (million), 2018-22
Table 7: Global gdp (constant 2005 prices, $ billion), 2018-22
Table 8: Global gdp (current prices, $ billion), 2018-22
Table 9: Global inflation, 2018-22
Table 10: Global consumer price index (absolute), 2018-22
Table 11: Global exchange rate, 2018-22
Table 12: Asia-Pacific generics market value: $ million, 2017-22
Table 13: Asia-Pacific generics market volume: %, 2017-22
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2022
Table 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Table 16: Asia-Pacific generics market volume forecast: %, 2022-27
Table 17: Europe generics market value: $ million, 2017-22
Table 18: Europe generics market volume: %, 2017-22
Table 19: Europe generics market geography segmentation: $ million, 2022
Table 20: Europe generics market value forecast: $ million, 2022-27
Table 21: Europe generics market volume forecast: %, 2022-27
Table 22: Europe size of population (million), 2018-22
Table 23: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 24: Europe gdp (current prices, $ billion), 2018-22
Table 25: Europe inflation, 2018-22
Table 26: Europe consumer price index (absolute), 2018-22
Table 27: Europe exchange rate, 2018-22
Table 28: France generics market value: $ million, 2017-22
Table 29: France generics market volume: %, 2017-22
Table 30: France generics market geography segmentation: $ million, 2022
Table 31: France generics market value forecast: $ million, 2022-27
Table 32: France generics market volume forecast: %, 2022-27
Table 33: France size of population (million), 2018-22
Table 34: France gdp (constant 2005 prices, $ billion), 2018-22
Table 35: France gdp (current prices, $ billion), 2018-22
Table 36: France inflation, 2018-22
Table 37: France consumer price index (absolute), 2018-22
Table 38: France exchange rate, 2018-22
Table 39: Germany generics market value: $ million, 2017-22
Table 40: Germany generics market volume: %, 2017-22
Table 41: Germany generics market geography segmentation: $ million, 2022
Table 42: Germany generics market value forecast: $ million, 2022-27
Table 43: Germany generics market volume forecast: %, 2022-27
Table 44: Germany size of population (million), 2018-22
Table 45: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 46: Germany gdp (current prices, $ billion), 2018-22
Table 47: Germany inflation, 2018-22
Table 48: Germany consumer price index (absolute), 2018-22
Table 49: Germany exchange rate, 2018-22
Table 50: Italy generics market value: $ million, 2017-22
Table 51: Italy generics market volume: %, 2017-22
Table 52: Italy generics market geography segmentation: $ million, 2022
Table 53: Italy generics market value forecast: $ million, 2022-27
Table 54: Italy generics market volume forecast: %, 2022-27
Table 55: Italy size of population (million), 2018-22
Table 56: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 57: Italy gdp (current prices, $ billion), 2018-22
Table 58: Italy inflation, 2018-22
Table 59: Italy consumer price index (absolute), 2018-22
Table 60: Italy exchange rate, 2018-22
Table 61: Japan generics market value: $ million, 2017-22
Table 62: Japan generics market volume: %, 2017-22
Table 63: Japan generics market geography segmentation: $ million, 2022
Table 64: Japan generics market value forecast: $ million, 2022-27
Table 65: Japan generics market volume forecast: %, 2022-27
Table 66: Japan size of population (million), 2018-22
Table 67: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 68: Japan gdp (current prices, $ billion), 2018-22
Table 69: Japan inflation, 2018-22
Table 70: Japan consumer price index (absolute), 2018-22
Table 71: Japan exchange rate, 2018-22
Table 72: Australia generics market value: $ million, 2017-22
Table 73: Australia generics market volume: %, 2017-22
Table 74: Australia generics market geography segmentation: $ million, 2022
Table 75: Australia generics market value forecast: $ million, 2022-27
Table 76: Australia generics market volume forecast: %, 2022-27
Table 77: Australia size of population (million), 2018-22
Table 78: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 79: Australia gdp (current prices, $ billion), 2018-22
Table 80: Australia inflation, 2018-22
Table 81: Australia consumer price index (absolute), 2018-22
Table 82: Australia exchange rate, 2018-22
Table 83: Canada generics market value: $ million, 2017-22
Table 84: Canada generics market volume: %, 2017-22
Table 85: Canada generics market geography segmentation: $ million, 2022
Table 86: Canada generics market value forecast: $ million, 2022-27
Table 87: Canada generics market volume forecast: %, 2022-27
Table 88: Canada size of population (million), 2018-22
Table 89: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 90: Canada gdp (current prices, $ billion), 2018-22
Table 91: Canada inflation, 2018-22
Table 92: Canada consumer price index (absolute), 2018-22
Table 93: Canada exchange rate, 2018-22
Table 94: China generics market value: $ million, 2017-22
Table 95: China generics market volume: %, 2017-22
Table 96: China generics market geography segmentation: $ million, 2022
Table 97: China generics market value forecast: $ million, 2022-27
Table 98: China generics market volume forecast: %, 2022-27
